Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
F Buccisano, L Maurillo, MI Del Principe… - Blood, The Journal …, 2012 - ashpublications.org
The choice of either induction or postremission therapy for adults with acute myeloid
leukemia is still largely based on the “one size fits all” principle. Moreover, pretreatment …
leukemia is still largely based on the “one size fits all” principle. Moreover, pretreatment …
[引用][C] Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia.
F Buccisano, L Maurillo, M DEL PRINCIPE… - BLOOD, 2012 - art.torvergata.it
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid
leukemia. IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie Settore …
leukemia. IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie Settore …
[引用][C] Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
F BUCCISANO, L MAURILLO, MI DEL PRINCIPE… - Blood, 2012 - pascal-francis.inist.fr
Prognostic and therapeutic implications of minimal residual disease detection in acute
myeloid leukemia CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
myeloid leukemia CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
[PDF][PDF] Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
F Buccisano, L Maurillo, MI Del Principe, G Del Poeta… - BLOOD, 2012 - academia.edu
The choice of either induction or postremission therapy for adults with acute myeloid
leukemia is still largely based on the “one size fits all” principle. Moreover, pretreatment …
leukemia is still largely based on the “one size fits all” principle. Moreover, pretreatment …
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia.
F Buccisano, L Maurillo, MI Del Principe, G Del Poeta… - Blood, 2011 - europepmc.org
The choice of either induction or postremission therapy for adults with acute myeloid
leukemia is still largely based on the" one size fits all" principle. Moreover, pretreatment …
leukemia is still largely based on the" one size fits all" principle. Moreover, pretreatment …
[HTML][HTML] Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
F Buccisano, L Maurillo, MI Del Principe, G Del Poeta… - Blood, 2012 - Elsevier
The choice of either induction or postremission therapy for adults with acute myeloid
leukemia is still largely based on the “one size fits all” principle. Moreover, pretreatment …
leukemia is still largely based on the “one size fits all” principle. Moreover, pretreatment …
[PDF][PDF] Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
F Buccisano, L Maurillo, MI Del Principe, G Del Poeta… - BLOOD, 2012 - thd.org.tr
The choice of either induction or postremission therapy for adults with acute myeloid
leukemia is still largely based on the “one size fits all” principle. Moreover, pretreatment …
leukemia is still largely based on the “one size fits all” principle. Moreover, pretreatment …
[PDF][PDF] Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
F Buccisano, L Maurillo, MI Del Principe… - …, 2012 - hemepathreview.com
The choice of either induction or postremission therapy for adults with acute myeloid
leukemia is still largely based on the “one size fits all” principle. Moreover, pretreatment …
leukemia is still largely based on the “one size fits all” principle. Moreover, pretreatment …
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
F Buccisano, L Maurillo, MI Del Principe… - …, 2012 - pubmed.ncbi.nlm.nih.gov
The choice of either induction or postremission therapy for adults with acute myeloid
leukemia is still largely based on the" one size fits all" principle. Moreover, pretreatment …
leukemia is still largely based on the" one size fits all" principle. Moreover, pretreatment …
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
F Buccisano, L Maurillo, MI Del Principe, G Del Poeta… - Blood, 2012 - cir.nii.ac.jp
抄録< jats: p> The choice of either induction or postremission therapy for adults with acute
myeloid leukemia is still largely based on the “one size fits all” principle. Moreover …
myeloid leukemia is still largely based on the “one size fits all” principle. Moreover …